Overview Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the safety and pharmacokinetics of KM-023 after single/multiple dosing. Phase: Phase 1 Details Lead Sponsor: Kainos Medicine Inc.